Latest: FDA Approves New Biosimilar for Oncology Treatment

Shocking! 1,705 deaths in Clinical Trials Since 2021, reveals RTI

0 Mins
In a grim reality, from 2021 till July 2025, clinical trials in India have seen 1,705 deaths and more than 7,000 serious adverse events, equivalent to one participant dying and four others suffering life-threatening complications every single day, according to data released by the Central Drugs Standard Control Organisation (CDSCO) through an RTI response. This information was provided by CDSCO in response to an RTI query, which had sought SAE-related data for Hyderabad and Telangana. Instead, the regulator shared nationwide figures. The CDSCO’s reply, accessed through an RTI application, shows that between 2021 and July 2025, 1,705 participants died due to Serious Adverse Events (SAEs) during clinical trials across the country. In the same period, 7,189 cases of non-fatal SAEs were recorded—an average of 4.2 people every day experiencing life-threatening side effects. For more details, check out the full story on the link mentioned below: One Death a Day: 1,705 Lives Lost in India's Clinical Trials Since 2021, RTI Reveals
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago